Newborn screening testing services
Ended Awarded
- Contract number
- HT941026FE138
- Awardee
-
Revvity Omics Inc. UEI LDJULX8K6M85 Part of Revvity Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $10,700
Award facts
- Contract value 100% obligated
- $10,700.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- South Korea
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency issued a delivery order to Revvity Omics Inc. on August 12, 2026, for newborn screening testing services, with a ceiling value of $10,700.48. Work is performed in South Korea on a firm fixed-price basis, with an ultimate completion date of September 28, 2026. No set-aside was used for this order.
Quick answers
Who was awarded contract HT941026FE138?
HT941026FE138 was awarded to Revvity Omics Inc. by Defense Health Agency (Department of Defense) on August 12, 2026.
How much is contract HT941026FE138 worth?
The government has obligated $10,700 on HT941026FE138.
Is contract HT941026FE138 an order under another contract?
Yes. HT941026FE138 is a delivery order under W81K0224D0009, an indefinite delivery contract.
Was contract HT941026FE138 competed?
The extent of competition for HT941026FE138 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award